Hidden health benefits from weight-loss shots revealed
How weight-loss jabs could help lower dementia risk
- New research indicates that weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer protection against serious conditions such as dementia and stroke.
- The study also suggests that individuals with type 2 diabetes and obesity prescribed these medications could face a reduced risk of premature death.
- Experts from Taiwan conducted a comprehensive study, examining data from 60,000 people worldwide with an average age of 58, all diagnosed with type 2 diabetes and obesity.
- During a seven-year follow-up, participants given GLP agonist drugs showed a 37 per cent lower risk of dementia, a 19 per cent reduced risk of stroke, and were 30 per cent less likely to die.
- Academics noted potential neuroprotective and cerebrovascular benefits but called for more studies, including randomised clinical trials, to confirm these findings.